Beximco Pharmaceuticals Limited Stock

Equities

BXPHARMA

BD0453BXPH04

Pharmaceuticals

End-of-day quote Dhaka S.E. 18:00:00 2024-05-08 EDT 5-day change 1st Jan Change
121.9 BDT -2.17% Intraday chart for Beximco Pharmaceuticals Limited +2.96% -16.62%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 44.51B 380M 521M Sales 2025 * 50.42B 431M 590M Capitalization 54.38B 465M 636M
Net income 2024 * 5.25B 44.89M 61.42M Net income 2025 * 6.24B 53.37M 73.03M EV / Sales 2024 * 1.36 x
Net Debt 2024 * 5.96B 50.91M 69.66M Net Debt 2025 * 878M 7.51M 10.27M EV / Sales 2025 * 1.1 x
P/E ratio 2024 *
9.91 x
P/E ratio 2025 *
8.08 x
Employees 5,700
Yield 2024 *
3.41%
Yield 2025 *
4.31%
Free-Float 76.68%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.17%
1 week+2.96%
Current month+2.44%
1 month+1.92%
3 months-13.05%
6 months-16.62%
Current year-16.62%
More quotes
1 week
118.40
Extreme 118.4
130.40
1 month
113.20
Extreme 113.2
130.40
Current year
110.00
Extreme 110
146.20
1 year
110.00
Extreme 110
146.20
3 years
110.00
Extreme 110
255.40
5 years
47.36
Extreme 47.3636
255.40
10 years
30.59
Extreme 30.5916
255.40
More quotes
Managers TitleAgeSince
Director of Finance/CFO 61 89-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Founder - 75-12-31
Founder - 75-12-31
Chief Executive Officer - 84-12-31
More insiders
Date Price Change Volume
24-05-09 121.9 -2.17% 159,671
24-05-08 124.6 -0.16% 97,297
24-05-07 124.8 -1.96% 415,991
24-05-06 127.3 +2.33% 273,497
24-05-05 124.4 +5.07% 329,791

End-of-day quote Dhaka S.E., May 08, 2024

More quotes
Beximco Pharmaceuticals Ltd. is a manufacturer and exporter of medicines in Bangladesh. The Company is engaged in manufacturing and marketing of generic pharmaceuticals formulation products covering a range of therapeutic categories. It offers products in different dosage forms including solid, liquid, cream and ointment, suppositories, metered dose inhaler, dry powder inhaler, nasal spray, sterile, lyophilized injectable and large volume intravenous fluids. It also manufactures active pharmaceutical ingredients (APIs) and renders contract manufacturing services to other companies. It produces different presentations, and the portfolio encompasses all key therapeutic categories, including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, dermatology, gastrointestinal and others. The Company's products include Atrizin, Nomos, Azithrocin, Ceftoril, Bemsivir, Viraflu, Viracin, Rilovir, Flurium, Nervalin, Seropam, Nightus, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
121.9 BDT
Average target price
168.3 BDT
Spread / Average Target
+38.09%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BXPHARMA Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW